Regulatory News As part of Cancer Moonshot, FDA seeks to prohibit menthol cigarettes, flavored cigars April 29, 2022Vol.48 No.17By Paul Goldberg
Drugs & Targets FDA grants clearance to ClearPoint Neuro’s SmartFrame Array version 1.1 April 29, 2022Vol.48 No.17
Clinical Roundup FDA OCE commentary: Cancer burden facing Asian Americans partly caused by racism April 22, 2022Vol.48 No.16
Drugs & Targets FDA grants priority review to Enhertu in previously treated HER2-mutant metastatic NSCLC April 22, 2022Vol.48 No.16
Conversation with The Cancer Letter At ODAC without sponsors, FDA highlights safety signals in PI3K inhibitor trials April 15, 2022Vol.48 No.15By Paul Goldberg
Drugs & Targets FDA fast tracks targeted breast cancer immunotherapy Bria-IMT April 15, 2022Vol.48 No.15
In Brief FDA seeks $8.4B to further investments in public health programs, including $20M for Cancer Moonshot efforts April 01, 2022Vol.48 No.13
Guest Editorial Single-country clinical trial results: Are they applicable to other populations? March 25, 2022Vol.48 No.12By Edward S. Kim
Drugs & Targets FDA approves Opdualag for unresectable or metastatic melanoma March 25, 2022Vol.48 No.12
